Market Tracker

07/03 4:45pm ET

Galena Biopharma Inc (NASDAQ:GALE)

1.68
Delayed Data
As of Jul 02
 -0.05 / -2.89%
Today’s Change
1.27
Today|||52-Week Range
3.20
+11.26%
Year-to-Date

Today’s Trading

Previous close1.73
Today’s open1.72
Day’s range1.67 - 1.73
Volume1,241,815
Average volume (3 months)3,383,037
Market cap$271.7M
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+63.53%
Earnings growth (this year)-3.23%
Earnings growth (next 5 years)--
Revenue growth (last year)+274.71%
P/E ratioNM
Price/Sales19.35
Price/Book5.87

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp-0.08-3.42%
VTAEVitae Pharmaceutical...-2.60-17.41%
AKBAAkebia Therapeutics ...+0.06+0.62%
THLDThreshold Pharmaceut...+0.07+1.80%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$9.3M
Annual profit (last year)-$36.6M
Net profit margin-392.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
Portland, Oregon

Forecasts